key: cord-0687110-cfullt04
authors: Moharir, S.; Sharath Chandra, S.; Goel, A.; Thakur, B.; Bhalla, G. S.; Kumar, D.; Naruka, D. S.; Kumar, A.; Tuli, A.; Suravaram, S.; Bingi, T. C.; Srinivas, M.; Mesipogu, R.; Reddy, K.; Khosla, S.; Tallapaka, K. B.; Mishra, R. K.
title: Detection of SARS-CoV-2 in the air from hospitals and closed rooms occupied by COVID-19 patients
date: 2021-01-04
journal: nan
DOI: 10.1101/2020.12.30.20248890
sha: b6a5143adbb10f6e6019560e638de5baedb12222
doc_id: 687110
cord_uid: cfullt04

To understand air transmission characteristics of SARS-CoV-2 and risks for health care personnel and visitors to hospitals, we analyzed air samples collected from various enclosures in hospitals at Hyderabad and Mohali and performed closed room experiments with COVID-19 positive individuals. We collected 64 air samples from COVID and non-COVID areas of various hospitals and 17 samples from closed rooms occupied by COVID patients. 4 samples from COVID care areas were positive for SARS-CoV-2 with no obvious predilection towards ICU/non-ICU areas in the hospital samples. In the closed room experiments, where one or more COVID-19 patients spent a short duration of time, one sample - collected immediately after the departure of three symptomatic patients from the room - was positive. Our results indicate that the chance of picking up SARS-CoV-2 in the air is directly related to a number of COVID positive cases in the room, their symptomatic status, and the duration of exposure and that the demarcation of hospital areas into COVID and non-COVID areas is a successful strategy to prevent cross infections. In neutral environmental conditions, the virus does not seem to spread farther away from the patients, especially if they are asymptomatic, giving an objective evidence for the effectiveness of physical distancing in curbing the spread of the epidemic.

procedure [17] . Rami et al. (2020) also suggested that, in hospitals, droplets containing SARS-CoV-2, with strong directional airflow, can spread the virus farther than 2 meters [18] .

To get further insights on transmission characteristics of SARS-CoV-2 in air and to assess the risk for healthcare workers, we collected air samples from different locations of hospitals and from closed rooms in which either one or more COVID positive individuals were present during sampling.

Hospital settings: Air samples were collected from three hospitals from Hyderabad, India -Hospital 1, Hospital 2 and Hospital 3; and three other hospitals from Mohali, India -Hospital 4, Hospital 5 and Hospital 6. Air samples were collected from COVID ICUs, nurse stations, COVID wards, corridors, non-COVID wards, PPE doffing areas, COVID rooms, OP corridors, mortuary, COVID casualty areas, non-COVID ICUs and doctors' rooms. The details of air sampling conditions are mentioned in Tables 2 & 3 and Supplementary Tables 1   & 2 .

Closed-room controlled experiments: Asymptomatic or mildly symptomatic COVID-19 positive individuals were asked to sit in a closed room during air sample collection procedure without masks and were allowed to talk over phone or interact with each other. Immediately after sample collection procedure was over, they were allowed to leave the room. Air samples from the closed room were collected prior to arrival of the COVID-19 positive individuals, from distances between 4 -12 feet from the individual, immediately after their departure and 2-6 hours post their departure. The pre-arrival and post departure samples were collected from the place where the participants sat in the room. The details of air sampling conditions are mentioned in Table 4 .

For closed-room experiments, nasopharyngeal swabs were collected in viral transfer medium (VTM) from the participants before air sampling (could not be done for one individual). The swabs were processed according to standard procedures and SARS-CoV-2 viral RNA Ct values were determined.

Air sample collection: Air samples were collected on disposable gelatin filters (Sartorius, Cat. No. 17528-80-ACD) using AirPort MD8 air sampler (Sartorius, Cat. No. 16757) . 1000 liters of air was collected at a flow rate of 50 liters per minute and a sampling time of 20 minutes. After sample collection, the gelatin membrane was aseptically removed, dissolved in 4 ml of Tris-EDTA buffer (10mM Tris and 0.1mM EDTA; pH 7.4) or VTM at 37°C in a water bath for 10 minutes or till it completely dissolved and then used for RNA extraction.

(exception -samples collected during sampling 1 at Hospital 4 and 5 in Mohali, were collected using Whatman filter paper placed on 90 mm petri dish using Merck's MAS-100® series air sampler, 1000 L at a rate of 100 liters per minute). The air samples were considered 'positive' when they satisfied positivity criteria as per the RT-PCR kit's specifications for clinical nasopharyngeal swab samples. Air samples were denoted as 'showing traces of SARS-CoV-2 RNA' when they did not fit the positivity criteria, but showed the following trends: either amplification of one of the SARS-CoV-2 viral genes in at least one of the triplicates or Ct values higher than the prescribed cut-offs (Ct> 36).

SARS-CoV-2 is detected in a few hospital air samples: We analyzed a total of 64 air samples from various locations at hospitals from two cities in India-Hyderabad and Mohali.

Out of the 64 samples collected, 4 samples collected from COVID care areas were positive for SARS-CoV-2 (Table 1) when they satisfied positivity criteria as per the RT-PCR kit's specifications for clinical nasopharyngeal swab samples. Air samples were denoted as 'showing traces of SARS-CoV-2 RNA' when they did not fit the positivity criteria, but showed the following trends: either amplification of one of the SARS-CoV-2 viral genes in at least one of the triplicates or Ct values higher than the prescribed cut-offs (Ct> 36).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ;

From Hyderabad, 41 air samples were collected from 3 hospitals between September 2020 and November 2020. Hospital 1 is a large tertiary care government hospital, being exclusively used for COVID care at the time of sample collection. Hospital 2 is a private trust hospital catering to very limited number of COVID patients while Hospital 3 is again a tertiary care government set-up catering to a moderate number of COVID patients along with other medical services. Of all the places tested, samples collected from an ICU and a COVID general ward in Hospital 1 and a nursing station in Hospital 3 were positive (Table 2) . From

Mohali, 23 air samples were collected from 3 hospitals (all tertiary care hospitals catering to moderate number of COVID and non COVID patients) between July and December. Among these, only one ICU sample in Hospital 5 was positive (Table 3) .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10. 1101 /2020 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.30.20248890 doi: medRxiv preprint nasopharyngeal swab samples. Air samples were denoted as 'showing traces of SARS-CoV-2 RNA' when they did not fit the positivity criteria, but showed the following trends: either amplification of one of the SARS-CoV-2 viral genes in at least one of the triplicates or Ct values higher than the prescribed cut-offs (Ct> 36 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10. 1101 /2020 For other samples, Fosun COVID-19 RT-PCR Detection Kit which detects SARS-CoV-2 E gene, N gene and . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10. 1101 /2020 In the initial phases of the pandemic, the transmission of SARS-CoV-2 was largely thought to be through contact and droplet spread. However, with studies reporting transmission among physically distanced individuals in closed spaces with air conditioning [18, 19] and the fact that, the viral spread could not be effectively curbed in spite of strict lockdowns in various countries of the world, raised the possibility of its airborne transmission. CDC also released a statement acknowledging the possibility of air borne transmission in certain scenarios (https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov-2.html).

In our study, from the air samples collected in hospitals, virus could be detected from various COVID care areas with no specific predilection towards ICU/ non-ICU areas. The virus could not be detected in any of the non-COVID areas, providing objective evidence that the strategy of separating hospital premises into COVID and non-COVID care areas is effective.

The positivity rate was found to be higher when the number of COVID patients were higher in the room, a finding concordant with results of closed room experiments as well. A point to be highlighted from the hospital experiments was that in 3/4 samples which were positive, the sampler was at least 10 feet away from the nearest patient. As there is no record on events that occurred in the sampling area before the sample collection began, we are unable to infer this finding. But this may be an indicator that long term presence of COVID positive patients in an enclosed space may contribute to a significant increase in aerosol burden in the air.

In our study, we found that the virus does not travel much in the air in neutral environmental conditions (ambient temperature and humidity with no perceived air flow), especially if duration of exposure is short. Virus could not be picked up at a distance of even 4 feet when COVID positive individuals spent a short time (20 minutes) in the room. This indicates that short duration of exposure to a COVID positive individual may not put one at a significantly increased risk. The samples collected at 8 feet and 12 feet subsequently were also negative. In . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; experiment 4, where three people with mild symptoms, were in a room for at least an hour, virus could be detected at the same place immediately after their departure. A finding strengthening the logic that chances of finding the virus in air are more when more number of symptomatic people stay in a closed place for longer periods. However, it is to be noted that many of the air samples from hospitals and closed room experiments showed PCR signal for one of the SARS-CoV-2 genes or had Ct values above the prescribed cut-off. The possibility that SARS-CoV-2 is actually present in these air . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi. org/10.1101 org/10. /2020 samples cannot be ruled out completely considering the diluting effect due to diffusion of the virus in air and the fact only 1000 liters (1 cubic meter) of air was sampled each time. If we consider these results as an evidence for presences of traces of viral RNA but not as negatives or false positives, all the propositions made in the paper so far still hold true except that the 

The authors declare no conflict of interest. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

1 . B a r - O n Y M , F l a m h o l z A , P h i l l i p s R , M i l o R . S A R S - C o V - 2 ( C O V I D - 1 9 ) b y t h e n u m b e r s . e L i f e 2 0 2 0 ; 9 . 2 . B a j J , K a r a k u ł a - J u c h n o w i c z H , T e r e s i ń s k i G , e t a l . C O V I D - 1 9 : S p e c i f i c a n d N o n - S p e c i f i c C l i n i c a l M a n i f e

The copyright holder for this preprint this version posted January 4, 2021. ;

. K  u  l  k  a  r  n  i  H  ,  S  m  i  t  h  C  M  ,  L  e  e  D  d  o  H  ,  H  i  r  s  t  R  A  ,  E  a  s  t  o  n  A  J  ,  O  '  C  a  l  l  a  g  h  a  n  C  .  E  v  i  d  e  n  c  e  o  f  R  e  s  p  i  r  a  t  o  r  y  S  y  n  c  y  t  i  a  l  V  i  r  u  s  S  p  r  e  a  d  b  y  A  e  r  o  s  o  l  .  T  i  m  e  t  o  R  e  v  i  s  i  t  I  n  f  e  c  t  i  o  n  C  o  n  t  r  o  l  S  t  r  a  t  e  g  i  e  s  ?  A  m  e  r  i  c  a  n  j  o  u  r  n  a  l  o  f  r  e  s  p  i  r  a  t  o  r  y  a  n  d  c  r  i  t  i  c  a  l  c  a  r  e  m  e  d  i  c  i  n  e  2  0  1  6  ;  1  9  4  :  3  0  8  -1  6  .  9 . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 4, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 4, 2021. ; https://doi.org/10. 1101 /2020 

No Sample People around Distance from the nearest patient Air conditioning Cross Ventilation Note